pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·Apr 29·1 min read
save

Federal autism advisory committee meets for first time in 19 months, targets support for profound autism

Apr 29, 2026·read at STAT ↗RegulatoryNeutral

The Interagency Autism Coordinating Committee held its first session in 19 months, convening after Health Secretary Robert F. Kennedy Jr. removed most of the panel’s scientific experts and appointed new members with activist backgrounds.

The committee, which advises the federal government on autism research priorities and oversees the allocation of hundreds of millions of dollars, turned its attention to individuals with the greatest support needs.

During the meeting, members voted to advance several proposals, including a recommendation to revise the scientific definition of "profound autism" to better reflect the needs of this population.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “In first meeting, federal autism committee focuses on ‘profound autism’”

read at STAT ↗
1,531 words · retrieved Apr 29
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
National Institutes of HealthUltragenyx Pharmaceutical Inc.University of Pennsylvania
topics
Vaccines3AdCom2Psychiatry & CNS2Rare DiseaseVaccine

related stories

  • Jun 5Tiny HHS office tasked with protecting research participants’ safety is running on fumesSTAT
  • Sep 25Federal judge rolls back landmark disability protectionsSTAT
  • Sep 14After a brief storm of political headwinds, mRNA is back with strong momentumBioSpace
  • Aug 6Opinion: One year since Kennedy canceled mRNA vaccine projects, science shows how wrong he wasSTAT
  • Jun 5Texas AG investigating energy drinksSTAT